On Saturday, the Susan G. Komen Race for the Cure will send thousands of breast cancer survivors and supporters walking together through Cleveland. Breast cancer has a strong following, but where's the momentum for curing other types of cancer? Are deadlier cancers such as that of the lung, liver and pancreas receiving enough federal cash for research? And what role do events like Race for the Cure play?
Guests
Dr. John Sweetenham, Vice Chair of Clinical Research at Cancer Institute, Cleveland Clinic
Dr. Mitchell Machtay, Chair of Radiation Oncology, University Hospitals
Diana Rowden, VP of Survivorship and Outcomes, Susan G. Komen for the Cure